1. Rakesh R, Azmi A, Regunath K, Azman R, Mun CL, Tassha H. Deep Vein Thrombosis and the Neurosurgical Patient. Malays J Med Sci. 2019;26:139.
2. Thomas LO, Ignacio N, Walter A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;19:4693.
3. Asma RK, Ali A, Vahid A. Economic evaluation of rivaroxaban versus enoxaparin for prevention of venous thromboembolism after total knee replacement and total hip replacement: A systematic review. Clin Drug Investig. 2020;08:715.
4. Scott DG, Richard EN, Kwame AN, Lisa CR, Gary ER. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res. 2016;137:3.
5. Kimon B, Nicos L, Shannon C, et al. Risk of venous thromboembolism and operative duration in patients undergoing neurosurgical procedures. Neurosurgery. 2017;05:787.